Development, evaluation and application of 3D QSAR Pharmacophore model in the discovery of potential human renin inhibitors

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1471-2105

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Development, evaluation and application of 3D QSAR Pharmacophore model in the discovery of potential human renin inhibitors ; volume:12 ; number:14 ; day:14 ; month:12 ; year:2011 ; pages:1-14 ; date:12.2011
BMC bioinformatics ; 12, Heft 14 (14.12.2011), 1-14, 12.2011

Creator: John, Shalini

Contributor: Thangapandian, Sundarapandian
Arooj, Mahreen
Hong, Jong Chan
Kim, Kwang Dong
Lee, Keun Woo
SpringerLink (Online service)

DOI: 10.1186/1471-2105-12-S14-S4

URN: urn:nbn:de:1111-2016021731412

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:37 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

John, Shalini
Thangapandian, Sundarapandian
Arooj, Mahreen
Hong, Jong Chan
Kim, Kwang Dong
Lee, Keun Woo
SpringerLink (Online service)

Other Objects (12)

Discovery of potential FGFR3 inhibitors via QSAR, pharmacophore modeling, virtual screening and molecular docking studies against bladder cancer

Pharmacophore-guided discovery of CDC25 inhibitors causing cell cycle arrest and tumor regression

In silico Discovery of Novel FXa Inhibitors by Pharmacophore Modeling and Molecular Docking

3D QSAR, pharmacophore and molecular docking studies of known inhibitors and designing of novel inhibitors for M18 aspartyl aminopeptidase of Plasmodium falciparum

In silico screening for identification of novel β-1,3-glucan synthase inhibitors using pharmacophore and 3D-QSAR methodologies

Lead generation of UPPS inhibitors targeting MRSA: Using 3D-QSAR pharmacophore modeling, virtual screening, molecular docking, and molecular dynamic simulations

Discovery of novel JAK1 inhibitors through combining machine learning, structure-based pharmacophore modeling and bio-evaluation

The discovery of potential acetylcholinesterase inhibitors: A combination of pharmacophore modeling, virtual screening, and molecular docking studies

QSAR and molecular docking for the search of AOX inhibitors: a rational drug discovery approach

QSAR analysis on tacrine-related acetylcholinesterase inhibitors

New sirtuin modulators: their uncovering, pharmacophore, and implications in drug discovery

Machine learning accelerates pharmacophore-based virtual screening of MAO inhibitors

Discovery of potential FGFR3 inhibitors via QSAR, pharmacophore modeling, virtual screening and molecular docking studies against bladder cancer

Pharmacophore-guided discovery of CDC25 inhibitors causing cell cycle arrest and tumor regression

In silico Discovery of Novel FXa Inhibitors by Pharmacophore Modeling and Molecular Docking

3D QSAR, pharmacophore and molecular docking studies of known inhibitors and designing of novel inhibitors for M18 aspartyl aminopeptidase of Plasmodium falciparum

In silico screening for identification of novel β-1,3-glucan synthase inhibitors using pharmacophore and 3D-QSAR methodologies

Lead generation of UPPS inhibitors targeting MRSA: Using 3D-QSAR pharmacophore modeling, virtual screening, molecular docking, and molecular dynamic simulations

Discovery of novel JAK1 inhibitors through combining machine learning, structure-based pharmacophore modeling and bio-evaluation

The discovery of potential acetylcholinesterase inhibitors: A combination of pharmacophore modeling, virtual screening, and molecular docking studies

QSAR and molecular docking for the search of AOX inhibitors: a rational drug discovery approach

QSAR analysis on tacrine-related acetylcholinesterase inhibitors

New sirtuin modulators: their uncovering, pharmacophore, and implications in drug discovery

Machine learning accelerates pharmacophore-based virtual screening of MAO inhibitors

Discovery of potential FGFR3 inhibitors via QSAR, pharmacophore modeling, virtual screening and molecular docking studies against bladder cancer

Pharmacophore-guided discovery of CDC25 inhibitors causing cell cycle arrest and tumor regression

In silico Discovery of Novel FXa Inhibitors by Pharmacophore Modeling and Molecular Docking

3D QSAR, pharmacophore and molecular docking studies of known inhibitors and designing of novel inhibitors for M18 aspartyl aminopeptidase of Plasmodium falciparum

In silico screening for identification of novel β-1,3-glucan synthase inhibitors using pharmacophore and 3D-QSAR methodologies

Lead generation of UPPS inhibitors targeting MRSA: Using 3D-QSAR pharmacophore modeling, virtual screening, molecular docking, and molecular dynamic simulations

Discovery of novel JAK1 inhibitors through combining machine learning, structure-based pharmacophore modeling and bio-evaluation

The discovery of potential acetylcholinesterase inhibitors: A combination of pharmacophore modeling, virtual screening, and molecular docking studies

QSAR and molecular docking for the search of AOX inhibitors: a rational drug discovery approach

QSAR analysis on tacrine-related acetylcholinesterase inhibitors

New sirtuin modulators: their uncovering, pharmacophore, and implications in drug discovery

Machine learning accelerates pharmacophore-based virtual screening of MAO inhibitors

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Development, evaluation and application of 3D QSAR Pharmacophore model in the discovery of potential human renin inhibitors

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Discovery of potential FGFR3 inhibitors via QSAR, pharmacophore modeling, virtual screening and molecular docking studies against bladder cancer

Pharmacophore-guided discovery of CDC25 inhibitors causing cell cycle arrest and tumor regression

In silico Discovery of Novel FXa Inhibitors by Pharmacophore Modeling and Molecular Docking

3D QSAR, pharmacophore and molecular docking studies of known inhibitors and designing of novel inhibitors for M18 aspartyl aminopeptidase of Plasmodium falciparum

In silico screening for identification of novel β-1,3-glucan synthase inhibitors using pharmacophore and 3D-QSAR methodologies

Lead generation of UPPS inhibitors targeting MRSA: Using 3D-QSAR pharmacophore modeling, virtual screening, molecular docking, and molecular dynamic simulations

Discovery of novel JAK1 inhibitors through combining machine learning, structure-based pharmacophore modeling and bio-evaluation

The discovery of potential acetylcholinesterase inhibitors: A combination of pharmacophore modeling, virtual screening, and molecular docking studies

QSAR and molecular docking for the search of AOX inhibitors: a rational drug discovery approach

QSAR analysis on tacrine-related acetylcholinesterase inhibitors

New sirtuin modulators: their uncovering, pharmacophore, and implications in drug discovery

Machine learning accelerates pharmacophore-based virtual screening of MAO inhibitors

Discovery of potential FGFR3 inhibitors via QSAR, pharmacophore modeling, virtual screening and molecular docking studies against bladder cancer

Pharmacophore-guided discovery of CDC25 inhibitors causing cell cycle arrest and tumor regression

In silico Discovery of Novel FXa Inhibitors by Pharmacophore Modeling and Molecular Docking

3D QSAR, pharmacophore and molecular docking studies of known inhibitors and designing of novel inhibitors for M18 aspartyl aminopeptidase of Plasmodium falciparum

In silico screening for identification of novel β-1,3-glucan synthase inhibitors using pharmacophore and 3D-QSAR methodologies

Lead generation of UPPS inhibitors targeting MRSA: Using 3D-QSAR pharmacophore modeling, virtual screening, molecular docking, and molecular dynamic simulations

Discovery of novel JAK1 inhibitors through combining machine learning, structure-based pharmacophore modeling and bio-evaluation

The discovery of potential acetylcholinesterase inhibitors: A combination of pharmacophore modeling, virtual screening, and molecular docking studies

QSAR and molecular docking for the search of AOX inhibitors: a rational drug discovery approach

QSAR analysis on tacrine-related acetylcholinesterase inhibitors

New sirtuin modulators: their uncovering, pharmacophore, and implications in drug discovery

Machine learning accelerates pharmacophore-based virtual screening of MAO inhibitors

Discovery of potential FGFR3 inhibitors via QSAR, pharmacophore modeling, virtual screening and molecular docking studies against bladder cancer

Pharmacophore-guided discovery of CDC25 inhibitors causing cell cycle arrest and tumor regression

In silico Discovery of Novel FXa Inhibitors by Pharmacophore Modeling and Molecular Docking

3D QSAR, pharmacophore and molecular docking studies of known inhibitors and designing of novel inhibitors for M18 aspartyl aminopeptidase of Plasmodium falciparum

In silico screening for identification of novel β-1,3-glucan synthase inhibitors using pharmacophore and 3D-QSAR methodologies

Lead generation of UPPS inhibitors targeting MRSA: Using 3D-QSAR pharmacophore modeling, virtual screening, molecular docking, and molecular dynamic simulations

Discovery of novel JAK1 inhibitors through combining machine learning, structure-based pharmacophore modeling and bio-evaluation

The discovery of potential acetylcholinesterase inhibitors: A combination of pharmacophore modeling, virtual screening, and molecular docking studies

QSAR and molecular docking for the search of AOX inhibitors: a rational drug discovery approach

QSAR analysis on tacrine-related acetylcholinesterase inhibitors

New sirtuin modulators: their uncovering, pharmacophore, and implications in drug discovery

Machine learning accelerates pharmacophore-based virtual screening of MAO inhibitors

Related objects

Reset password